BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36218127)

  • 1. Montreal cognitive assessment as a screening instrument for cognitive impairment in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.
    Lim XR; Chew POK; Lim GH; Low YL; Lim JWP; Ong HN; Law WG; Tan JWL; Thong BY; Chia FL; Lian TY; Chan GYL; Chan MT; Koh ET; Kong KO; Howe HS
    Lupus; 2022 Dec; 31(14):1759-1769. PubMed ID: 36218127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
    Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
    Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
    Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
    Tayer-Shifman OE; Yuen K; Green R; Kakvan M; Katz P; Bingham KS; Diaz-Martinez JP; Ruttan L; Wither JE; Tartaglia MC; Su J; Bonilla D; Choi MY; Appenzeller S; Barraclough M; Beaton DE; Touma Z
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):569-577. PubMed ID: 35724303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
    Nantes SG; Su J; Dhaliwal A; Colosimo K; Touma Z
    J Rheumatol; 2017 Nov; 44(11):1583-1589. PubMed ID: 28864643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunction in SLE: development of a screening tool.
    Adhikari T; Piatti A; Luggen M
    Lupus; 2011 Oct; 20(11):1142-6. PubMed ID: 21676920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia.
    Kanapathy A; Nik Jaafar NR; Shaharir SS; Chan LF; Rozita M; Ch'ng SS
    Lupus; 2019 Jun; 28(7):854-861. PubMed ID: 31159651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly.
    Chalhoub NE; Luggen ME
    Lupus; 2019 Jan; 28(1):51-58. PubMed ID: 30482092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
    Paez-Venegas N; Jordan-Estrada B; Chavarria-Avila E; Perez-Vazquez F; Gómez-Bañuelos E; Medina-Dávalos R; Ontiveros-González JÁ; Diaz-Rubio GI; Navarro-Hernandez RE; Vázquez-Del Mercado M
    J Clin Rheumatol; 2019 Dec; 25(8):325-328. PubMed ID: 31764492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of cognitive impairment and cognitive improvement in patients with systemic lupus erythematosus during a 6-month follow-up study.
    Koolvisoot A; Chumjang S
    Lupus; 2023 Sep; 32(10):1199-1210. PubMed ID: 37592859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life.
    Kim MY; Sen D; Drummond RR; Brandenburg MC; Biesanz KL; Kim AH; Eisen SA; Baum CM; Foster ER
    Lupus; 2021 Jun; 30(7):1100-1107. PubMed ID: 33794707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive dysfunction, obsessive-compulsive symptoms, and attention deficit and hyperactivity disorder in Systemic Lupus Erythematosus: Evidence for basal ganglia dysfunction?
    Maciel RO; Ferreira GA; Akemy B; Cardoso F
    J Neurol Sci; 2016 Jan; 360():94-7. PubMed ID: 26723981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction in patients with systemic lupus erythematosus. A cross-sectional study in a Brazilian sample.
    Borba EA; Scoto Dias E; Tercziany Vanzin JH; Ferreira de Queiroz Junior N; Dos Santos TAF; Skare T; Nisihara R
    Lupus; 2023 Jun; 32(7):900-909. PubMed ID: 37204123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Disease Activity, Levels of IFN-a, IL-4, IL-6, and Anti-NMDA to Cognitive Dysfunction (MoCA-INA Score) in Systemic Lupus Erythematosus (SLE) Patients with Cognitive Dysfunction.
    Suntoko B; Hadisaputro S; Kalim H; Hadi S; Saputra WA
    Acta Med Indones; 2023 Jul; 55(3):307-314. PubMed ID: 37915160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
    Ceccarelli F; Pirone C; Mina C; Mascolo A; Perricone C; Massaro L; Spinelli FR; Alessandri C; Valesini G; Conti F
    PLoS One; 2019; 14(11):e0224437. PubMed ID: 31682630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing.
    Koll TT; Sheese AN; Semin J; Ernst W; High R; Wildes TM; Fisher A; Murman DL
    J Geriatr Oncol; 2020 Mar; 11(2):297-303. PubMed ID: 31831362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms.
    Hagen E; Sømhovd M; Hesse M; Arnevik EA; Erga AH
    J Subst Abuse Treat; 2019 Feb; 97():21-27. PubMed ID: 30577896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus impairs memory cognitive tests not affected by depression.
    Calderón J; Flores P; Babul M; Aguirre JM; Slachevsky A; Padilla O; Scoriels L; Henríquez C; Cárcamo C; Bravo-Zehnder M; González A; Massardo L
    Lupus; 2014 Sep; 23(10):1042-53. PubMed ID: 24879658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.
    Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
    Asian J Psychiatr; 2022 Apr; 70():103029. PubMed ID: 35189473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Mini-Mental State Examination and Montreal Cognitive Assessment executive subtests in detecting post-stroke cognitive impairment.
    Fu C; Jin X; Chen B; Xue F; Niu H; Guo R; Chen Z; Zheng H; Wang L; Zhang Y
    Geriatr Gerontol Int; 2017 Dec; 17(12):2329-2335. PubMed ID: 28675607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.